Thank you doesn't seem enough for our melanoma nurses.
28 May 2021
'Sarah is more than a nurse – she’s my supporter, my confidante and my friend. Thank you just doesn’t seem enough.’ - Lauren, melanoma patient
Sarah is one of our much loved nurses who provides direct care and support for our melanoma patients throughout their treatment journey.
Our melanoma nurses care for patients across Sydney, the Riverina and in Western Australia, and provide support for patients in remote and regional areas via telehealth.
No matter what support a patient needs – from post-surgery or clinic support, to guiding through a clinical trial or support in the community – our melanoma nurses are there.
Like Sarah is to Lauren, our nurses become like family.
‘Sarah was the first person I met when I came in for treatment at Melanoma Institute Australia, and from that moment onwards I didn’t feel alone. Cancer is frightening, but Sarah has been my rock. She has been there for all my treatments and all my scans and follow-up appointments. I don’t know how I would have survived it all without her.’ - mother of two, 46 year-old Lauren Walker.
Melanoma Institute Australia has a growing network of nurses to provide support for patients with all stages of melanoma, and also to help educate and raise awareness about melanoma prevention and early detection.
Whilst our research and clinical teams are trialling new treatments to save lives from melanoma, it is our nurses who are on the front line. Quite simply, we couldn’t save lives without them.
‘It was Sarah who I called for re-assurance when I had side effects from treatment. It was Sarah who supported me when I was really unwell in hospital, and it was Sarah who shared my elation when I was told I was finally cancer free,’ - Lauren
‘Thank you just doesn’t seem enough.'
Our melanoma nurses are our unsung heroes who are critical to the care our patients receive in all of our clinics, every day. Without them, we won’t achieve our mission of zero deaths from melanoma this decade.
We need your help to continue funding them, so please donate today for the benefit of all melanoma patients, now and in the future. Any gift you can generously give this tax time will help us continue to fund our melanoma nurses.
Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.
A larger, monthly dose of immunotherapy can give melanoma patients more freedom without sacrificing effectiveness.
The Australasian Melanoma Conference, hosted by the Australasian Melanoma Conference Committee, was held in Melbourne on the weekend, with many of MIA's clinicians in attendance.
The two men who discovered checkpoint inhibitors, the brakes of the immune system, were awarded the Nobel Prize in Physiology or Medicine on Monday, October 1.
The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.